Spirair receives US FDA clearance for TurbAlign, a new bioabsorbable implant that helps keep nasal passages open after sinus ...

A bioabsorbable mechanoelectric fiber as electrical stimulation suture Journal: Nature Communications Published: 2024-10-08 DOI: 10.1038/s41467-024-52354-x Affiliations: 5 Authors: 15 Go to article ...

Researchers from IMDEA Materials, in conjunction with the Helmholtz-Zentrum Hereon Institute of Surface Science and Meotec ...

The market for bioabsorbable stents was valued at US$ 159.6 million in 2021 and is anticipated to reach US$ 165.4 million by the end of 2022. The market’s sales are anticipated to grow at a CAGR of ...

Major players in the bioabsorbable stents market are Abbott Laboratories, Reva Medical, Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc. , Zorion Medical, Tepha, Inc. , S3V ...

The majority of bioabsorbable devices available on the market are made up of polyesters, chiefly homopolymers and copolymers of polyglycolic acid (PGA) and poly-L-lactic acid (PLLA).

LONDON--(BUSINESS WIRE)--The bioabsorbable stents market is expected to grow by USD 5.68 billion during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of ...

BEIJING - China has granted market access to a new bioabsorbable vascular stent for treating coronary artery diseases, according to the National Medical Products Administration. Produced by a ...

Bioabsorbable scaffolds may be considered the new threshold in endovascular treatment. The National Institutes of Health (NIH) report that the most frequent form of heart disease is coronary ...

In the ABSORB trial, the feasibility of using a fully bioabsorbable everolimus-eluting stent (BVS; Abbott Vascular, Santa Clara, CA) in patients with ischemia and a single de novo coronary lesion ...

BEIJING -- Chinese scientists have developed a fully bioabsorbable capacitor as an energy storage unit, which can be used for powering implantable medical electronics. Biodegradable electronic ...

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. P W Serruys, J A Ormiston, V Onuma, et al. Lancet 2009;373: 897-910.